Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

26 August 2022 (11:15 - 12:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Takumi Noda

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

Doctor K. Berge (Nordbyhagen, NO)

Abstract Slides

Presentation thumbnail

Introduction of a new scoring tool to identify clinically stable heart failure patients

Mr A. Gingele (Maastricht, NL)

Abstract Slides

Presentation thumbnail

A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)

Doctor K. McDowell (Glasgow, GB)

Abstract Slides

Presentation thumbnail

Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials

Doctor C. Adamson (Larbert, GB)

Abstract Slides

Presentation thumbnail

MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study

Doctor F. Kerwagen (Wuerzburg, DE)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - Prognosis and prediction of outcome

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

NT Pro BNP management in heart failure: time to act

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources